These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Defects in the interferon-gamma and interleukin-12 pathways. Rosenzweig SD; Holland SM Immunol Rev; 2005 Feb; 203():38-47. PubMed ID: 15661020 [TBL] [Abstract][Full Text] [Related]
24. Innate defects of the IL-12/IFN-γ axis in susceptibility to infections by mycobacteria and salmonella. Ramirez-Alejo N; Santos-Argumedo L J Interferon Cytokine Res; 2014 May; 34(5):307-17. PubMed ID: 24359575 [TBL] [Abstract][Full Text] [Related]
25. Human host genetic factors in mycobacterial and Salmonella infection: lessons from single gene disorders in IL-12/IL-23-dependent signaling that affect innate and adaptive immunity. van de Vosse E; Ottenhoff TH Microbes Infect; 2006 Apr; 8(4):1167-73. PubMed ID: 16513390 [TBL] [Abstract][Full Text] [Related]
26. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Jouanguy E; Lamhamedi-Cherradi S; Lammas D; Dorman SE; Fondanèche MC; Dupuis S; Döffinger R; Altare F; Girdlestone J; Emile JF; Ducoulombier H; Edgar D; Clarke J; Oxelius VA; Brai M; Novelli V; Heyne K; Fischer A; Holland SM; Kumararatne DS; Schreiber RD; Casanova JL Nat Genet; 1999 Apr; 21(4):370-8. PubMed ID: 10192386 [TBL] [Abstract][Full Text] [Related]
27. [From gene to disease; mutations in interleukin-12-receptor-beta 1- and interferon-gamma-receptor-1 lead to nontuberculous mycobacterial infections and salmonellosis]. van Dissel JT; Ottenhoff TH Ned Tijdschr Geneeskd; 2000 Sep; 144(38):1830-2. PubMed ID: 11020837 [TBL] [Abstract][Full Text] [Related]
32. Three novel compound heterozygous IL12RB1 mutations in Chinese patients with Mendelian susceptibility to mycobacterial disease. Zhou X; Jia W; Ni Z; Wang A; Liu Z; Hou M; Zhou M; Tang Z; Zhang D; Li L; Han T; Tan Y; Luo G; Wang J; Wu Y; Zhang X PLoS One; 2019; 14(4):e0215648. PubMed ID: 30998751 [TBL] [Abstract][Full Text] [Related]
33. A 1,100-year-old founder effect mutation in IL12B gene is responsible for Mendelian susceptibility to mycobacterial disease in Tunisian patients. Ben-Mustapha I; Ben-Ali M; Mekki N; Patin E; Harmant C; Bouguila J; Elloumi-Zghal H; Harbi A; Béjaoui M; Boughammoura L; Chemli J; Barbouche MR Immunogenetics; 2014 Jan; 66(1):67-71. PubMed ID: 24127073 [TBL] [Abstract][Full Text] [Related]
34. Current Status of the Management of Mendelian Susceptibility to Mycobacterial Disease in Mainland China. Ying W; Liu D; Dong X; Wang W; Hui X; Hou J; Yao H; Zhou Q; Sun B; Sun J; Wang X J Clin Immunol; 2019 Aug; 39(6):600-610. PubMed ID: 31367980 [TBL] [Abstract][Full Text] [Related]
35. Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity. Holland SM Immunol Res; 2007; 38(1-3):342-6. PubMed ID: 17917041 [TBL] [Abstract][Full Text] [Related]
36. Clinical and host genetic characteristics of Mendelian susceptibility to mycobacterial diseases in Japan. Hoshina T; Takada H; Sasaki-Mihara Y; Kusuhara K; Ohshima K; Okada S; Kobayashi M; Ohara O; Hara T J Clin Immunol; 2011 Jun; 31(3):309-14. PubMed ID: 21221749 [TBL] [Abstract][Full Text] [Related]
37. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. Al-Muhsen S; Casanova JL J Allergy Clin Immunol; 2008 Dec; 122(6):1043-51; quiz 1052-3. PubMed ID: 19084105 [TBL] [Abstract][Full Text] [Related]
38. Clinical and immunological profile of children with Mendelian Susceptibility to Mycobacterial Diseases (MSMD) from an Indian tertiary care hospital. Indumathi CK; Bustamante J Indian J Tuberc; 2021 Apr; 68(2):292-297. PubMed ID: 33845970 [TBL] [Abstract][Full Text] [Related]